The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma

被引：0
|
作者：
Zhou, Lijun [1 ]
Liu, Xiande [1 ]
Sun, Mianen [1 ]
Tannir, Nizar M. [1 ]
Laird, Douglas [2 ]
Jonasch, Eric [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Exelixis Inc, San Francisco, CA USA
来源：
ANGIOGENESIS | 2014年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P-128
引用
收藏
页码：774 / 774
页数：1
相关论文
共 50 条
  • [21] IL-17 mediates resistance to anti-VEGF therapy
    Maniati, Eleni
    Hagemann, Thorsten
    NATURE MEDICINE, 2013, 19 (09) : 1092 - 1094
  • [22] Pharmakologische Basis der Anti-VEGF TherapiePharmacological basis of the anti-VEGF therapy
    Leopold Schmetterer
    Gerhard Garhöfer
    Spektrum der Augenheilkunde, 2012, 26 (4) : 185 - 196
  • [23] Anti-VEGF therapy by hydrodynamic delivery suppresses growth of renal cell carcinoma that expresses multiple pro-angiogenic factors
    Yazawa, H
    Murakami, T
    Back, T
    Suzuki, Y
    Parsoneault, E
    Gruys, M
    Wiltrout, R
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S30 - S30
  • [24] The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
    Lieu, Christopher H.
    Hai Tran
    Jiang, Zhi-Qin
    Mao, Muling
    Overman, Michael J.
    Lin, E.
    Eng, Cathy
    Morris, Jeffrey
    Ellis, Lee
    Heymach, John V.
    Kopetz, Scott
    PLOS ONE, 2013, 8 (10):
  • [25] Cloaking VEGF in small extracellular vesicles as a cause of adaptive resistance to anti-VEGF therapy
    Ma, Shaolin
    Mangala, Lingegowda S.
    Hu, Wen
    Bayaktar, Emine
    Hu, Wei
    Jennings, Nicholas B.
    Coleman, Robert L.
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Anti-VEGF maintenance therapy of patients with advanced metastatic colorectal carcinoma
    Holubec, Lubos
    Liska, Vaclav
    Fiala, Ondrej
    Finek, Jindrich
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S84 - S84
  • [27] Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
    Zahra, Fatema Tuz
    Sajib, Md. Sanaullah
    Mikelis, Constantinos M.
    CANCERS, 2021, 13 (06) : 1 - 18
  • [28] Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition
    Piao, Yuji
    Liang, Ji
    Holmes, Lindsay
    Henry, Verlene
    Sulman, Erik
    de Groot, John F.
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4392 - 4403
  • [29] Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma
    Hato, Tai
    Zhu, Andrew X.
    Duda, Dan G.
    IMMUNOTHERAPY, 2016, 8 (03) : 299 - 313
  • [30] Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)
    Mitamura, T.
    Pradeep, S.
    McGuire, M.
    Wu, S. Y.
    Ma, S.
    Hatakeyama, H.
    Lyons, Y. A.
    Hisamatsu, T.
    Noh, K.
    Villar-Prados, A.
    Chen, X.
    Ivan, C.
    Rodriguez-Aguayo, C.
    Hu, W.
    Lopez-Berestein, G.
    Coleman, R. L.
    Sood, A. K.
    ONCOGENE, 2018, 37 (06) : 722 - 731
12345